ArticleBiomedicines2022

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.

Keiichi Haga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.